Prednisolone

A corticosteroid that suppresses inflammation. In two small trials in early schizophrenia, a six-week course did not clearly help.

At a glance

Type
Medicine: corticosteroid
Used for
Tested as an add-on to antipsychotics in recent-onset schizophrenia
Status
Experimental
Evidence
EarlyHow evidence is rated
Administration
Tablets, added to an antipsychotic. In the trials, a six-week course that started high and was reduced to zero
Common side effects
Higher blood sugar, a higher white blood cell count
In Europe
Tested in the Netherlands, Belgium, Denmark and Norway
Clinical summaryFor health professionals

What it is

Prednisolone is a corticosteroid, a synthetic form of a hormone the body makes to restrain inflammation. It acts broadly on the immune system and passes from the blood into the brain.1 It was tested in schizophrenia on the idea that inflammation contributes to the illness in some people.2

How well it works

A trial led from UMC Utrecht, with hospitals in the Netherlands, Belgium and Denmark, gave 42 people with schizophrenia that had begun within the previous seven years either a six-week course of prednisolone or a placebo, on top of their usual treatment. Symptoms improved in both groups to the same degree. The trial stopped early because recruitment was slow.2

A trial in Bergen, Stavanger and Trondheim used the same course. It planned to include 90 people but stopped after 12 because of the COVID-19 pandemic. Symptoms tended to improve more on prednisolone, but the difference was not clear enough to rule out chance.1

Across 70 trials of add-on treatments with possible anti-inflammatory effects, medicines designed to suppress inflammation did no better than the others.3

Side effects

In the Utrecht-led trial, no serious side effects occurred during treatment.2 In the Norwegian trial, blood sugar and the white blood cell count rose on prednisolone, psychotic and manic symptoms did not worsen, and the three serious adverse events all occurred on placebo.1

High doses of corticosteroids can bring on psychiatric symptoms.4 In autoimmune psychosis (opens in a new tab), where the immune system is the proven cause, they are part of the standard treatment.5

What we don’t know yet

  • Whether a course of corticosteroids helps people with schizophrenia who have clear signs of inflammation.

Sources

  1. Hoprekstad GE, Johnsen E, Bartz-Johannessen C, et al. Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study. Brain, Behavior, and Immunity – Health. 2025;48:101047.
    DOI (opens in a new tab)PubMed (opens in a new tab)
  2. Nasib LG, Gangadin SS, Rossum IWV, et al. The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial. Schizophrenia Research. 2021;230:79–86.
    DOI (opens in a new tab)PubMed (opens in a new tab)
  3. Jeppesen R, Christensen RHB, Pedersen EMJ, et al. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysis. Brain, Behavior, and Immunity. 2020;90:364–380.
    DOI (opens in a new tab)PubMed (opens in a new tab)
  4. Mulic-Al Bunni S, Gschwind M, Finkener S, et al. The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management. Advances in Therapy. 2026;43(5):1891–1925.
    DOI (opens in a new tab)PubMed (opens in a new tab)
  5. Pollak TA, Lennox BR, Müller S, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatry. 2020;7(1):93–108.
    DOI (opens in a new tab)PubMed (opens in a new tab)

Not medical advice. Talk to a doctor before starting or changing any treatment. Disclaimer

Spotted an error? Tell us. Corrections are dated and listed on Corrections.

Page last reviewed: 5 November 2026Next review due: May 2027

The Commissure newsletter

Monthly research updates.